Implementation of a mobile technology supported cardiovascular disease prevention program in Indonesia and North India.
Not Applicable
Completed
- Registration Number
- CTRI/2017/08/009387
- Lead Sponsor
- George Institute for Global Health Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 584
Inclusion Criteria
participants between 40-85 years
Exclusion Criteria
Respondents where measurements for blood pressure, height and weight not possible i.e. incapacitated respondents
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Indonesia: Difference in the change in the proportion from baseline to end-of-study of high risk individuals prescribed appropriate preventive medications between the intervention and control arms. <br/ ><br> <br/ ><br>India: Difference in the proportion of high risk individuals prescribed appropriate preventive medications between the screening phase (identified by ASHA) and end of the study evaluation (among those identified as high risk by ASHA during screening)Timepoint: By February 2018
- Secondary Outcome Measures
Name Time Method Indonesia: Diff in the change in the proportion from baseline to end-of-study (EOS) of high risk individuals (HRI) achieving SBP less than 140mmHg between the int and cont arms. <br/ ><br>Diff in mean reduction in BP levels between the int and cont arms. <br/ ><br>% of HRI correctly referred and followed-up by NPHWs in the intervention arm. <br/ ><br> <br/ ><br>India: % HRI correctly referred by NPHWs to PHC doctors <br/ ><br>% HRI receiving follow-up visits by NPHWs <br/ ><br>% HRI achieving blood pressure targetsTimepoint: By February 2018